Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Clin Cancer Res. 2013 Feb 5;19(7):1729–1739. doi: 10.1158/1078-0432.CCR-12-1907

Table 2.

Level of mutant JAK2 V617F allele frequency in granulocytes does not correlate with response to inhibition of phosphoSTAT5

Stratified byJAK2 V617F allele freq Mean allele freq (%) Mean % pSTAT5 AT 20μM n
All patients with JAK2 V617 mutation
< 50% 17 49.6 5
> 50% 74 48.6 11

Polycythemia Vera/Essential Thrombocytosis
< 50% 31 4.05 2
> 50% 75 35.74 7

Myelofibrosis
< 50% 8 80.03 3
> 50% 73 71.02 4